 |
|
|
|
|
Twofold Action Urged for Pre-Diabetes
Goal is to prevent progression to the full-blown disease and its huge costs
By Steven Reinberg
HealthDay Reporter
|
| | | | Related Healthscout Videos | |
|
WEDNESDAY, July 23 (HealthDay News) -- Lifestyle changes, coupled with a reduction in heart disease risks, will go a long way toward preventing pre-diabetes from progressing to the full-blown disease, experts from the American Association of Clinical Endocrinologists (AACE) recommend.
Pre-diabetes occurs when blood sugar levels or impaired glucose tolerance is elevated, but not quite to the point defined as diabetes. More than 56 million Americans currently suffer from pre-diabetes, according to the U.S. Centers for Disease Control and Prevention.
Text Continues Below
"Diabetes has become the major problem in the United States," Dr. Harold Lebovitz, a professor of medicine at the division of endocrinology and metabolism/diabetes at the State University of New York Health Sciences Center at Brooklyn, said during a noon teleconference Wednesday.
Lebovitz noted that diabetes is the main cause of kidney failure and most blindness in adults, and causes about 60 percent of cardiovascular diseases.
"The issue is, do you wait until patients really develop these catastrophic complications?" Lebovitz said. "Last year, it cost $170 billion in direct and indirect costs to take care of people with diabetes."
The growing epidemic of diabetes in the United States will continue to cost more, unless something is done to halt it, Lebovitz noted. "Diabetes starts at an earlier stage, called pre-diabetes," he said. "The question arises, should you wait for pre-diabetic patients to develop diabetes and the complications, or should you take a preventive approach?"
The AACE is pressing for aggressive action to keep pre-diabetes from progressing to full-blown diabetes. The first step involves lifestyle changes, such as diet and exercise. "It will cost a lot of money to develop lifestyle programs, but in the long run we will save trillions of dollars in health care," Lebovitz said.
Page: 1 | 2 | Next >>
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 7/23/2008
|
|
SOURCES: July 23, 2008, teleconference with Harold Lebovitz, M.D., professor, medicine, division of endocrinology and metabolism/diabetes, State University of New York Health Sciences Center at Brooklyn, New York City; Daniel Einhorn, M.D., vice president, American Association of Clinical Endocrinologists, and medical director, Scripps Whittier Institute for Diabetes, La Jolla, Calif.
|
.gif)
